We've found
3,902
archived clinical trials in
Irritable Bowel Syndrome (IBS)
We've found
3,902
archived clinical trials in
Irritable Bowel Syndrome (IBS)
B. Lactis HN019 for Constipation-predominant Irritable Bowel Syndrome (IBS)
Updated: 12/19/2011
Effects of 4-week Bifidobacterium Lactis HN019 Supplementation on Whole Gut Transit Time and Gastrointestinal Symptoms in Adults With Constipation-predominant Irritable Bowel Syndrome: A Double-blind, Randomized, Placebo-controlled Dose-ranging Trial
Status: Enrolling
Updated: 12/19/2011
B. Lactis HN019 for Constipation-predominant Irritable Bowel Syndrome (IBS)
Updated: 12/19/2011
Effects of 4-week Bifidobacterium Lactis HN019 Supplementation on Whole Gut Transit Time and Gastrointestinal Symptoms in Adults With Constipation-predominant Irritable Bowel Syndrome: A Double-blind, Randomized, Placebo-controlled Dose-ranging Trial
Status: Enrolling
Updated: 12/19/2011
Click here to add this to my saved trials
Abdominal Symptom Phenotype Study in Children
Updated: 3/15/2012
Abdominal Symptom Phenotype: Pathways to New Biomarkers
Status: Enrolling
Updated: 3/15/2012
Abdominal Symptom Phenotype Study in Children
Updated: 3/15/2012
Abdominal Symptom Phenotype: Pathways to New Biomarkers
Status: Enrolling
Updated: 3/15/2012
Click here to add this to my saved trials
Gut Microbial Transplantation in Pediatric Inflammatory Bowel Diseases
Updated: 3/22/2012
Gut Microbial Transplantation in Pediatric Inflammatory Bowel Diseases
Status: Enrolling
Updated: 3/22/2012
Gut Microbial Transplantation in Pediatric Inflammatory Bowel Diseases
Updated: 3/22/2012
Gut Microbial Transplantation in Pediatric Inflammatory Bowel Diseases
Status: Enrolling
Updated: 3/22/2012
Click here to add this to my saved trials
Levels of the Stat4 Alpha and Stat4 Beta Isoforms in PBMCs From Patients With Crohn's Disease and Ulcerative Colitis
Updated: 4/3/2012
Levels of the Stat4 Alpha and Stat4 Beta Isoforms in PBMCs From Patients With Crohn's Disease and Ulcerative Colitis
Status: Enrolling
Updated: 4/3/2012
Levels of the Stat4 Alpha and Stat4 Beta Isoforms in PBMCs From Patients With Crohn's Disease and Ulcerative Colitis
Updated: 4/3/2012
Levels of the Stat4 Alpha and Stat4 Beta Isoforms in PBMCs From Patients With Crohn's Disease and Ulcerative Colitis
Status: Enrolling
Updated: 4/3/2012
Click here to add this to my saved trials
Pregabalin on Colonic Motor and Sensory Function in Constipation Predominant Irritable Bowel Syndrome
Updated: 5/24/2012
Effect of Pregabalin on Colonic Motor and Sensory Function in Adults With Irritable Bowel Syndrome With Predominant Constipation
Status: Enrolling
Updated: 5/24/2012
Pregabalin on Colonic Motor and Sensory Function in Constipation Predominant Irritable Bowel Syndrome
Updated: 5/24/2012
Effect of Pregabalin on Colonic Motor and Sensory Function in Adults With Irritable Bowel Syndrome With Predominant Constipation
Status: Enrolling
Updated: 5/24/2012
Click here to add this to my saved trials
Managing Inflammatory Bowel Disease
Updated: 6/12/2012
Psychosocial Intervention for Children With IBD
Status: Enrolling
Updated: 6/12/2012
Managing Inflammatory Bowel Disease
Updated: 6/12/2012
Psychosocial Intervention for Children With IBD
Status: Enrolling
Updated: 6/12/2012
Click here to add this to my saved trials
Cohort Study of Bowel Function Following Robotic-assisted Laparoscopic Sacrocolpopexy
Updated: 6/12/2012
Cohort Study of Bowel Function Following Robotic-assisted Laparoscopic Sacrocolpopexy
Status: Enrolling
Updated: 6/12/2012
Cohort Study of Bowel Function Following Robotic-assisted Laparoscopic Sacrocolpopexy
Updated: 6/12/2012
Cohort Study of Bowel Function Following Robotic-assisted Laparoscopic Sacrocolpopexy
Status: Enrolling
Updated: 6/12/2012
Click here to add this to my saved trials
Mindfulness-Based Stress Reduction and the Microbiome
Updated: 6/12/2012
Pyrosequencing to Identify Alterations in Intestinal Microbiota Following a Stress Reduction Course
Status: Enrolling
Updated: 6/12/2012
Mindfulness-Based Stress Reduction and the Microbiome
Updated: 6/12/2012
Pyrosequencing to Identify Alterations in Intestinal Microbiota Following a Stress Reduction Course
Status: Enrolling
Updated: 6/12/2012
Click here to add this to my saved trials
Cyclophosphamide in Treating Young Patients With Severe Autoimmune Enteropathy
Updated: 6/13/2012
High-Dose Cyclophosphamide for the Treatment of Severe Autoimmune Enteropathy
Status: Enrolling
Updated: 6/13/2012
Cyclophosphamide in Treating Young Patients With Severe Autoimmune Enteropathy
Updated: 6/13/2012
High-Dose Cyclophosphamide for the Treatment of Severe Autoimmune Enteropathy
Status: Enrolling
Updated: 6/13/2012
Click here to add this to my saved trials
Vitamin D Treatment in Ulcerative Colitis
Updated: 7/16/2012
Vitamin D Treatment in Ulcerative Colitis
Status: Enrolling
Updated: 7/16/2012
Vitamin D Treatment in Ulcerative Colitis
Updated: 7/16/2012
Vitamin D Treatment in Ulcerative Colitis
Status: Enrolling
Updated: 7/16/2012
Click here to add this to my saved trials
Sucrose Breath Test to Determine Intestinal Permeability in IBS
Updated: 8/27/2012
The Use of a Novel 13C Sucrose Breath Test (13C SBT) to Determine Intestinal Permeability in Irritable Bowel Syndrome (IBS) Patients
Status: Enrolling
Updated: 8/27/2012
Sucrose Breath Test to Determine Intestinal Permeability in IBS
Updated: 8/27/2012
The Use of a Novel 13C Sucrose Breath Test (13C SBT) to Determine Intestinal Permeability in Irritable Bowel Syndrome (IBS) Patients
Status: Enrolling
Updated: 8/27/2012
Click here to add this to my saved trials
Milnacipran (Savella) in Irritable Bowel Syndrome (IBS)
Updated: 9/7/2012
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy of Milnacipran in the Treatment of Irritable Bowel Syndrome
Status: Enrolling
Updated: 9/7/2012
Milnacipran (Savella) in Irritable Bowel Syndrome (IBS)
Updated: 9/7/2012
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy of Milnacipran in the Treatment of Irritable Bowel Syndrome
Status: Enrolling
Updated: 9/7/2012
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Updated: 10/3/2012
Research Study to Evaluate LOTRONEX® in Severe IBS-D: Analysis of Current Clinical Practice Environment
Status: Enrolling
Updated: 10/3/2012
Click here to add this to my saved trials